Advanced search
Publication Cover
International Journal of Neuroscience Volume 124, 2014 - Issue 11
Submit an article Journal homepage
99
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Interleukin-10-1082A/G and −592C/A Polymorphisms with risk of Parkinson's disease: a meta-analysis

Jun JinDepartment of Neurology, Zhujiang Hospital of Southern Medical University, Guangzhou, China
,
Peihua WuDepartment of Neurology, Zhujiang Hospital of Southern Medical University, Guangzhou, China
,
Wuying LiDepartment of Neurology, Zhujiang Hospital of Southern Medical University, Guangzhou, China
,
Jian ShiDepartment of Neurology, Zhujiang Hospital of Southern Medical University, Guangzhou, China
,
Jian ChenDepartment of Neurology, Zhujiang Hospital of Southern Medical University, Guangzhou, China
,
Rong LiDepartment of Neurology, Zhujiang Hospital of Southern Medical University, Guangzhou, China
&
Sheng TanDepartment of Neurology, Zhujiang Hospital of Southern Medical University, Guangzhou, ChinaCorrespondencetansheng18@ 126.com
 show all
Pages 852-858 | Received 30 Oct 2013, Accepted 05 Jan 2014, Published online: 07 Feb 2014

References

  • Hakansson A, Westberg L, Nilsson S, Investigation of genes coding for inflammatory components in Parkinson's disease. Mov Disord 2005;20:569–573.
  • Warner TT, Schapira AH. Genetic and environmental factors in the cause of Parkinson's disease. Ann Neurol 2003;53(Suppl 3):S16–23, S23–5.
  • Lee YB, Nagai A, Kim SU. Cytokines, chemokines, and cytokine receptors in human microglia. J Neurosci Res 2002;69: 94–103.
  • Bessler H, Djaldetti R, Salman H, IL-1 beta, IL-2, IL-6 and TNF-alpha production by peripheral blood mononuclear cells from patients with Parkinson's disease. Biomed Pharmacother 1999;53:141–145.
  • Schulte T, Schols L, Muller T, Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's disease. Neurosci Lett 2002;326:70–72.
  • Strle K, Zhou JH, Shen WH, Interleukin-10 in the brain. Crit Rev Immunol 2001;21:427–449.
  • Bialecka M, Klodowska-Duda G, Kurzawski M, Interleukin-10 gene polymorphism in Parkinson's disease patients. Arch Med Res 2007;38:858–863.
  • Iyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol 2012;32:23–63.
  • Bialecka M, Klodowska-Duda G, Kurzawski M, Interleukin-10 (IL10) and tumor necrosis factor alpha (TNF) gene polymorphisms in Parkinson's disease patients. Parkinsonism Relat Disord 2008;14:636–640.
  • Infante J, Garcia-Gorostiaga I, Sanchez-Juan P, Inflammation-related genes and the risk of Parkinson's disease: a multilocus approach. Eur J Neurol 2008;15:431–433.
  • Pascale E, Passarelli E, Purcaro C, Lack of association between IL-1beta, TNF-alpha, and IL-10 gene polymorphisms and sporadic Parkinson's disease in an Italian cohort. Acta Neurol Scand 2011;124:176–181.
  • Li D, He Q, Li R, Interleukin-10 promoter polymorphisms in Chinese patients with Parkinson's disease. Neurosci Lett 2012;513:183–186.
  • Nie K, Zhang Y, Gan R, Polymorphisms in immune/ inflammatory cytokine genes are related to Parkinson's disease with cognitive impairment in the Han Chinese population. Neurosci Lett 2013;541:111–115.
  • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603–605.
  • Attia J, Thakkinstian A, D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol 2003;56:297–303.
  • DerSimonian R. Meta-analysis in the design and monitoring of clinical trials. Stat Med 1996;15:1237–1248, 1249–1252.
  • Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22:719–748.
  • Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629–634.
  • Chu K, Zhou X, Luo BY. Cytokine gene polymorphisms and Parkinson's disease: a meta-analysis. Can J Neurol Sci 2012; 39:58–64.
  • Driver JA, Logroscino G, Gaziano JM, Kurth T. Incidence and remaining lifetime risk of Parkinson disease in advanced age. Neurology 2009;72:432–438.
  • Ghione I, Di Fonzo A, Saladino F, Parkin polymorphisms and environmental exposure: decrease in age at onset of Parkinson's disease. Neurotoxicology 2007;28:698–701.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.